EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management

Lisa M Gudenkauf iD, Struan Gray iD, Brian D Gonzalez iD, Ashwin Sachdeva iD, Karen Autio iD

American Society of Clinical Oncology Educational Book · 2024

DOI: 10.1200/edbk_433126 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Lisa M Gudenkauf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. Hauptthemen laut MEDLINE: Androgen Antagonists, Prostatic Neoplasms, Quality of Life. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgen-deprivation therapy (ADT) is well established as the standard of care in metastatic prostate cancer (PCa) management; however, ADT has significant adverse effects (AEs) that must be addressed. This review aims to highlight opportunities to mitigate AEs of ADT and explore alternatives in PCa management. Specifically, we discuss behavioral and pharmacologic strategies for mitigating ADT AEs as well as ADT-sparing approaches for hormone-sensitive and castration-resistant PCa. Equipped with effective mitigation strategies and possible alternatives, clinicians and researchers can optimize health-related quality of life for patients currently receiving ADT for PCa and consider treatments that spare patients from AEs of ADT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Androgen AntagonistsProstatic NeoplasmsQuality of LifeHumansMaleAntineoplastic Agents, HormonalDisease Management

Substanzen

Androgen AntagonistsAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.
  • Salford Royal and The Christie NHS Foundation Trusts, Manchester, United Kingdom.
  • Genito-urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.
  • The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

ORCID-Profile: Lisa M Gudenkauf, Struan Gray, Brian D Gonzalez, Ashwin Sachdeva, Karen Autio

Zitieren

APA

Gudenkauf, L. M., Gray, S., Gonzalez, B. D., Sachdeva, A., & Autio, K. (2024). Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_433126

Vancouver

Gudenkauf LM, Gray S, Gonzalez BD, Sachdeva A, Autio K. Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_433126

BibTeX
@article{Gudenkauf2024,
  author = {Gudenkauf, Lisa M and Gray, Struan and Gonzalez, Brian D and Sachdeva, Ashwin and Autio, Karen},
  title = {Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2024},
  doi = {10.1200/edbk_433126}
}
Kostenlos starten →